| Venous Thromboembolism Prevention in Outpatients With Glioma (NCT05683808) | University of Vermont Medical Center | 2023-01-16 |
| Nitric Oxide Gas Inhalation for Severe Acute Respiratory Syndrome in COVID-19. (NCT04290871) | Xijing Hospital | 2023-01-16 |
| Study of SGN1 in Patients With Advanced Solid Tumor (NCT05038150) | Guangzhou Sinogen Pharmaceutical Co., Ltd | 2023-01-16 |
| Optimization of Postoperative Adjuvant Therapy for Cervical Cancer Based on MRD(Minimal Residual Disease) (NCT05872724) | Suzhou Municipal Hospital | 2023-01-16 |
| ASPirin in Immune thRombocytopenia Patients With Cardiovascular disEase (NCT04912505) | University Hospital, Toulouse | 2023-01-16 |
| Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Invasion (NCT05625893) | Samsung Medical Center | 2023-01-15 |
| Repeated Intranasal Esketamine Plus Almond Therapy in Participants With Treatment Resistant Depressive Disorder - 3 Month Extension Study (NCT05438758) | Zylorion Health | 2023-01-15 |
| 177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs (NCT04915144) | British Columbia Cancer Agency | 2023-01-15 |
| Prevention of Severe Acute Graft-versus-host Disease in Adult Patients Using a daGOAT Model (NCT05600855) | Institute of Hematology & Blood Diseases Hospital, China | 2023-01-15 |
| Deep-sea Fish Oil for Prevention of Acute Radiation-induced Esophagitis (NCT06392971) | First Affiliated Hospital of Chengdu Medical College | 2023-01-15 |
| A Healthy Volunteer Trial Investigating MR-enterography Image Quality of Lumentin® 44 (NCT05781490) | Lument AB | 2023-01-15 |
| Research Project: Pilot Study on Oral Urea Use in Patients at High Risk of Kidney Stone Recurrence (NCT04727606) | Centre hospitalier de l'Université de Montréal (CHUM) | 2023-01-15 |
| Ibudilast for Treating Alcohol Use Disorder (NCT05414240) | University of Pennsylvania | 2023-01-14 |
| Efficacy of Megadose Vitamin C in Severe and Critical Ill COVID-19 Patients. (NCT05694975) | Zhujiang Hospital | 2023-01-13 |
| Study to Assess Efficacy and Safety of Dupilumab in the Treatment of Keloids (NCT05128383) | Beth Israel Deaconess Medical Center | 2023-01-13 |
| Optimizing(O) RIfapentine-based(RI) Regimen and shortENing(EN) the Treatment of Drug-sensitive Tuberculosis(T) (NCT05401071) | Huashan Hospital | 2023-01-13 |
| PPIO-004 Clinical Application of Efficacy Prediction Model Based on Epigenomics Sequencing Technology in Neoadjuvant Immunotherapy for Esophageal Cancer (NCT05880082) | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 2023-01-13 |
| Testing the Safety and Effectiveness of Combining Two Drugs, PLX2853 and Trametinib in the Treatment of Advanced Uveal Melanoma (NCT05677373) | Alliance for Clinical Trials in Oncology | 2023-01-13 |
| A Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer (NCT05705635) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2023-01-13 |
| A Clinical Study in Children With Heterozygous Familial Hypercholesterolemia (HeFH) Aged 6 to 17 Treated Once Daily With Bempedoic Acid Oral Dosing (CLEAR Path 1) (NCT05694260) | Esperion Therapeutics, Inc. | 2023-01-12 |
| Study of SBRT/Olaparib Followed by Pembrolizumab/Olaparib in Gastric Cancers (NCT05379972) | University of Colorado, Denver | 2023-01-12 |
| A Study to Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Participants Aged ≥18 Years With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype (LIBERTY-UC SUCCEED (Study in UC for Clinical Efficacy Evaluation of Dupilumab)) (NCT05731128) | Sanofi | 2023-01-12 |
| The Clinical Significance of Peripheral Blood T Lymphocyte PD-1 Expression and T Cell Subset Distribution. (NCT06029829) | Xin-Hua Xu | 2023-01-12 |
| Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC) (NCT05660083) | The Methodist Hospital Research Institute | 2023-01-12 |
| Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumors (NCT05438420) | Qurient Co., Ltd. | 2023-01-12 |
| Metformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia (NCT05237960) | University of Arizona | 2023-01-12 |
| A Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients With Sickle Cell Disease (NCT06198712) | Forma Therapeutics, Inc. | 2023-01-12 |
| Durvalumab Combined With Chemotherapy Neoadjuvant Therapy of Biliary Tract Cancer (NCT05640791) | Tianjin Medical University Cancer Institute and Hospital | 2023-01-12 |
| FOLFOXIRI-based HAIC Combined With Fuquintinib as Late-line Treatment in Patients With CRLM：A Phase 2 Single-Arm Clinical Trial (NCT07024537) | Meng Qiu | 2023-01-12 |
| A Phase I/II Study of LM-101 Injection in Patients With Advanced Malignant Tumors (NCT05615974) | LaNova Medicines Limited | 2023-01-11 |
| Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer (NCT05573126) | Ellipses Pharma | 2023-01-11 |
| A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease (NCT05668013) | Teva Branded Pharmaceutical Products R&D LLC | 2023-01-11 |
| Efficacy of Bumetanide to Improve Cognitive Functions in Down Syndrome (NCT06465823) | Stefano Vicari | 2023-01-11 |
| Diazepam Trial in GAD65 Associated Epilepsy (NCT05361447) | Mayo Clinic | 2023-01-11 |
| Precision Alemtuzumab Dosing for Allogeneic Hematopoietic Cell Transplantation (NCT05501756) | Children's Hospital Medical Center, Cincinnati | 2023-01-11 |
| Probiotic Blend in Reducing Anthropometric Measurements in Obese Adults (NCT05676229) | Universidade do Extremo Sul Catarinense - Unidade Academica de Ciecias da Saude | 2023-01-11 |
| Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer (NCT06173986) | Shanghai Chest Hospital | 2023-01-10 |
| Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis (NCT05554302) | Baptist Health South Florida | 2023-01-10 |
| A Dose-ranging Trial of OPC-131461 in Cardiac Edema (Congestive Heart Failure [CHF]) (NCT05615363) | Otsuka Pharmaceutical Co., Ltd. | 2023-01-10 |
| Study of Dotatate Imaging in Breast Cancer (NCT05880394) | Hoag Memorial Hospital Presbyterian | 2023-01-10 |
| Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis (NCT05758493) | Oregon Health and Science University | 2023-01-10 |
| A Prospective Phase II Study for Adjuvant Hypofractionated Intensity-modulated Proton Radiotherapy for Post Operative Breast Cancer With Implantation Reconstruction (NCT05692674) | Shanghai Proton and Heavy Ion Center | 2023-01-10 |
| Serplulimab Combined With Anti-VEGF Antibody in Advanced Lung Adenocarcinoma (NCT05675033) | Fujian Cancer Hospital | 2023-01-10 |
| Study of Nab-Paclitaxel and Gemcitabine and Plus/Minus VCN-01 in Patients With Metastatic Pancreatic Cancer (NCT05673811) | Theriva Biologics SL | 2023-01-10 |
| Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection (NCT05616221) | Armata Pharmaceuticals, Inc. | 2023-01-10 |
| A Double-Blind, Placebo-Controlled Study of Fermented Deglycyrrhizinated Licorice Extract (NCT07148804) | Helwan University | 2023-01-10 |
| REStoring lymphoCytes Using NKTR-255* After chemoradiothErapy in Solid Tumors (RESCUE) (NCT05632809) | M.D. Anderson Cancer Center | 2023-01-10 |
| Nivolumab in Children and Adults With Nasopharyngeal Carcinoma (NCT06019130) | German Society for Pediatric Oncology and Hematology GPOH gGmbH | 2023-01-10 |
| Venetoclax Plus IM2 Regimen for Relapsed and Refractory T Lymphoblastic Lymphoma/Leukemia (NCT05576532) | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2023-01-10 |
| Exogenous Ketone Esters for Drug Resistant Epilepsy (NCT05670847) | Sohag University | 2023-01-10 |
| Phase 2b Study of ALTO-100 in MDD (NCT05712187) | Alto Neuroscience | 2023-01-10 |
| Exogenous Ketone Esters for Refractory Status Epileptics (NCT05674552) | Sohag University | 2023-01-10 |
| Red Light Photobiomodulation and Topical Disinfectants (NCT05797818) | Ondine Biomedical Inc. | 2023-01-10 |
| Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same Donor (NCT05508009) | Alice Bertaina | 2023-01-10 |
| Roflumilast Versus Methotrexate in Psoriasis (NCT05684744) | Cairo University | 2023-01-09 |
| Phase 1b/2a Study of GSBR-1290 in Adult Overweight or Obese Healthy Subjects and Subjects With Type 2 Diabetes Mellitus (NCT05762471) | Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics | 2023-01-09 |
| A Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With EFP; Cellulite (Stage 1) (NCT05632926) | Caliway Biopharmaceuticals Co., Ltd. | 2023-01-09 |
| Assessment of Antioxidant Therapy on Oxidative Stress Biomarkers in Type 2 Diabetic Patients With Neuropathy (NCT06131918) | Khyber Medical University Peshawar | 2023-01-09 |
| Safety and Efficacy of STSP-0601 in Adult Patients With Hemophilia A or B Without Inhibitor (NCT05619926) | Staidson (Beijing) Biopharmaceuticals Co., Ltd | 2023-01-09 |
| A Study of TAK-861 in Participants With Narcolepsy Type 2 (NCT05687916) | Takeda | 2023-01-09 |
| A Study of TAK-861 in Participants With Narcolepsy Type 1 (NCT05687903) | Takeda | 2023-01-09 |
| Safety and Tolerability of A3907 in Primary Sclerosing Cholangitis (NCT05642468) | Albireo, an Ipsen Company | 2023-01-09 |
| Phase II/III Trial of PRL3-Zumab in Advanced Solid Tumor Patients (NCT07290088) | Intra-IMMUSG Pte Ltd | 2023-01-09 |
| Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption (NCT05419024) | National Cancer Institute (NCI) | 2023-01-09 |
| Lateral Ridge Augmentation Using Two Graft Combination and a Cross-linked Collagen Membrane (NCT06523686) | Saint-Joseph University | 2023-01-09 |
| Impact of CardiolRxTM on Recurrent Pericarditis (MAvERIC-Pilot) (NCT05494788) | Cardiol Therapeutics Inc. | 2023-01-09 |
| A Study to Investigate the Antitumor Activity, Safety, Tolerability, and Pharmacokinetics of BGB-A445 in Combination With Tislelizumab in Participants With Select Advanced Solid Tumors. (NCT05661955) | BeiGene | 2023-01-09 |
| A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002) (NCT05506943) | Compass Therapeutics | 2023-01-09 |
| BXQ-350 in Newly Diagnosed Metastatic Colorectal Carcinoma (NCT05322590) | Bexion Pharmaceuticals, Inc. | 2023-01-09 |
| Xanthohumol as an Adjuvant in the Treatment of Septic Shock (NCT06225258) | Medical University of Lublin | 2023-01-09 |
| Improving the Treatment of Acute Relapses in Multiple Sclerosis Through Intranasal Methylprednisolone Administration (NCT06223074) | Universidad Nacional Autonoma de Mexico | 2023-01-09 |
| Pembrolizumab With or Without Lenvatinib or Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer (NCT06230471) | Peking Union Medical College Hospital | 2023-01-09 |
| Study Of ATRN-119 In Patients With Advanced Solid Tumors (NCT04905914) | Aprea Therapeutics | 2023-01-09 |
| Safety and Immunogenicity Study of Recombinant Trivalent Rotavirus Subunit Vaccine in Healthy Infants and Toddlers (NCT05621655) | MAXVAX Biotechnology Limited Liability Company | 2023-01-08 |
| A Clinical Trial of BMX-010 in Adult Subjects With Atopic Dermatitis (NCT05491447) | BioMimetix JV, LLC | 2023-01-08 |
| Application of Al18F-NOTA-FAPI PET/CT in Malignant Tumors Expressing Fibroblast-activated Proteins (NCT05749302) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2023-01-08 |
| Immunogenicity and Safety of COVID-19 Vaccine in Population Aged 18 Years and Above (NCT05663086) | Guangzhou Patronus Biotech Co., Ltd. | 2023-01-07 |
| Neoadjuvant Lenvatinib and Pembrolizumab for IVC Tumor Thrombus (NCT05319015) | University of Texas Southwestern Medical Center | 2023-01-06 |
| Clinical Study to Evaluate the Possible Efficacy of Metformin in Patients With Parkinson's Disease (NCT05781711) | Tanta University | 2023-01-06 |
| NP137 Clinical and Biological Activities Assessment in Patients With Advanced/Metastatic Solid Tumors Treated by Standard Anti PD-1/PD-L1 Immunotherapies (NCT05605496) | Centre Leon Berard | 2023-01-06 |
| Evaluate Azvudine in Preventing SARS-Cov-2 Infection in Household Contacts of Covid-19 in China (NCT05682599) | Shanghai Henlius Biotech | 2023-01-06 |
| Understanding the Role of Gut Microbiota in Hyperphagia in Prader-Willi Syndrome (NCT05541003) | Rutgers, The State University of New Jersey | 2023-01-06 |
| Medroxyprogesterone Acetate Plus Atorvastatin in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia (NCT05675787) | Peking University People's Hospital | 2023-01-06 |
| Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare (NCT05658575) | Olatec Therapeutics, Inc. | 2023-01-06 |
| Ketamine & Crisis Response Plan for Suicidal Ideation in the ED (NCT05696691) | The University of Texas Health Science Center at San Antonio | 2023-01-06 |
| Effect of Intravenous Iron Repletion on Renal Function in Patients With Iron Deficiency and Acute Kidney Injury (NCT05960227) | Hospital Civil de Guadalajara | 2023-01-06 |
| A Trial of NIS793 With FOLFIRINOX in Pancreatic Cancer (NCT05546411) | Kimberly Perez, MD | 2023-01-06 |
| Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBC (NCT05464082) | University of Utah | 2023-01-06 |
| Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Bacterial Conjunctivitis (NCT05816070) | IVIEW Therapeutics Inc. | 2023-01-05 |
| GBT021601-022: A Study of GBT021601 in Participants With Sickle Cell Disease (SCD) (NCT05632354) | Pfizer | 2023-01-05 |
| Treatment With Human Umbilical Cord-derived Mesenchymal Stromal Cells in Systemic Sclerosis (NCT04356287) | Marie Hudson, MD | 2023-01-05 |
| Ph2 Study of Savolitinib and Durvalumab (MEDI4736) Combination in Advanced MET Amplified Gastric Cancer(VIKTORY-2) (NCT05620628) | Jeeyun Lee | 2023-01-05 |
| Plaque Inhibitory Effect of Neutral Electrolysed Water in the Form of a Mouthwash in a 4-day Non-brushing Model (NCT05709015) | University of Ljubljana | 2023-01-05 |
| Rituximab in Patients With Acute Rheumatic Fever (NCT05682196) | African Academy of Methodology and Statistics | 2023-01-05 |
| Oxygen Atomizing Inhalation of EGCG in the Treatment Interstitial Pneumonia in Cancer Patients (NCT05758571) | Shandong Cancer Hospital and Institute | 2023-01-05 |
| Post-Autologous Transplant Maintenance With Isatuximab and Lenalidomide in Minimal Residual Disease Positive Multiple Myeloma (NCT05344833) | University of Illinois at Chicago | 2023-01-05 |
| Acalabrutinib, Venetoclax and Durvalumab for the Treatment of Richter Transformation From Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT05388006) | Mayo Clinic | 2023-01-05 |
| Antibiotic Instillation in Appendicitis (NCT05470517) | Johns Hopkins All Children's Hospital | 2023-01-05 |
| Probiotics Strains for Infant Colic (NCT05685030) | Universidade do Extremo Sul Catarinense - Unidade Academica de Ciecias da Saude | 2023-01-05 |
| Clinical Trial to Evaluate the Safety and Efficacy of SCAI-001 Compared to Restasis (NCT05733624) | SCAI Therapeutics | 2023-01-05 |